• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Tositumomab and Iodine I 131 Tositumomab Product Approval Information - Licensing Action 6/27/03

Proper name: Tositumomab and Iodine I 131 Tositumomab 
Tradename: Bexxar
Manufacturer: Corixa Corporation, Seattle, WA, License #1614
Indication for Use: Treatment of patients with CD20 positive, follicular, non-Hodgkin's lymphoma, with and without transformation, whose disease is refractory to Rituximab and has relapsed following chemotherapy
Approval Date: 6/27/2003
Type of submission: Biologics license application


Labeling (PDF)